165 related articles for article (PubMed ID: 33779474)
1. Outcomes of adult T-Cell leukemia/lymphoma with allogeneic stem cell transplantation: single-institution experience.
Epstein-Peterson ZD; Ganesan N; Barker JN; Drullinsky PR; Ghione P; Jakubowski AA; Kumar A; Moskowitz AJ; Noy A; Perales MA; Ponce DM; Schoder H; Young JW; Giralt SA; Horwitz SM; Sauter CS; Dahi PB
Leuk Lymphoma; 2021 Sep; 62(9):2177-2183. PubMed ID: 33779474
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Allogeneic Hematopoietic Cell Transplantation in Human T Cell Lymphotropic Virus Type 1-Associated Adult T Cell Leukemia/Lymphoma: Results of a Systematic Review/Meta-Analysis.
Iqbal M; Reljic T; Klocksieben F; Sher T; Ayala E; Murthy H; Bazarbachi A; Kumar A; Kharfan-Dabaja MA
Biol Blood Marrow Transplant; 2019 Aug; 25(8):1695-1700. PubMed ID: 31132453
[TBL] [Abstract][Full Text] [Related]
3. Stem cell therapy for HTLV-1 induced adult T-cell leukemia/lymphoma (ATLL): A comprehensive review.
Gholamzad A; Khakpour N; Gholamzad M; Roudaki Sarvandani MR; Khosroshahi EM; Asadi S; Rashidi M; Hashemi M
Pathol Res Pract; 2024 Mar; 255():155172. PubMed ID: 38340584
[TBL] [Abstract][Full Text] [Related]
4. Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell Transplantation.
Gupta VK; El-Jawahri A; Orkev G; Johnson MH; Weinberg J; Goodrich C; Janakiram M; Sloan JM
Transplant Cell Ther; 2022 May; 28(5):276.e1-276.e5. PubMed ID: 35123118
[TBL] [Abstract][Full Text] [Related]
5. Barriers to Allogeneic Hematopoietic Stem Cell Transplantation for Human T Cell Lymphotropic Virus 1-Associated Adult T Cell Lymphoma-Leukemia in the United States: Experience from a Large Cohort in a Major Tertiary Center.
Adrianzen Herrera D; Kornblum N; Acuna-Villaorduna A; Sica RA; Shah U; Butler M; Vishnuvardhan N; Shah N; Bachier-Rodriguez L; Derman O; Shastri A; Mantzaris I; Verma AK; Braunschweig I; Janakiram M
Biol Blood Marrow Transplant; 2019 Jun; 25(6):e199-e203. PubMed ID: 30769194
[TBL] [Abstract][Full Text] [Related]
6. Small number of HTLV-1-positive cells frequently remains during complete remission after allogeneic hematopoietic stem cell transplantation that are heterogeneous in origin among cases with adult T-cell leukemia/lymphoma.
Yamasaki R; Miyazaki Y; Moriuchi Y; Tsutsumi C; Fukushima T; Yoshida S; Taguchi J; Inoue Y; Matsuo E; Imaizumi Y; Imanishi D; Fujimoto T; Tsushima H; Honda S; Hata T; Tsukasaki K; Tomonaga M
Leukemia; 2007 Jun; 21(6):1212-7. PubMed ID: 17410191
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approaches for HTLV-1-associated adult T-cell leukemia/lymphoma: a comprehensive review.
Letafati A; Soheili R; Norouzi M; Soleimani P; Mozhgani SH
Med Oncol; 2023 Sep; 40(10):295. PubMed ID: 37689806
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and prognosis in 12 patients with adult T cell leukemia/lymphoma confirmed by HTLV-1 provirus gene detection].
Wu ZJ; Zheng XY; Yang XZ; Liu TB; Yang T; Zheng ZH; Gao F; Chen CX; Li JG; Zhang CQ; Lin WQ; Zheng HY; Lin SX; Hu JD
Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1027-1032. PubMed ID: 28088963
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of young-onset adult T cell leukemia/lymphoma and preceding chronic refractory eczema and corneal injury by allogeneic hematopoietic stem cell transplantation.
Miyamura F; Kako S; Yamagami H; Sato K; Sato M; Terasako K; Kimura SI; Nakasone H; Aoki S; Okuda S; Yamazaki R; Oshima K; Yoshinaga K; Higuchi T; Nishida J; Demitsu T; Kakehashi A; Kanda Y
Int J Hematol; 2009 Oct; 90(3):397-401. PubMed ID: 19705056
[TBL] [Abstract][Full Text] [Related]
11. Adult T-cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy.
Zell M; Assal A; Derman O; Kornblum N; Battini R; Wang Y; Narasimhulu DM; Mantzaris I; Shastri A; Verma A; Ye H; Braunschweig I; Janakiram M
Oncotarget; 2016 Aug; 7(32):51981-51990. PubMed ID: 27341021
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation.
Motohashi K; Suzuki T; Kishimoto K; Numata A; Nakajima Y; Tachibana T; Ohshima R; Kuwabara H; Tanaka M; Tomita N; Ishigatsubo Y; Fujisawa S
Int J Hematol; 2013 Aug; 98(2):258-60. PubMed ID: 23801427
[TBL] [Abstract][Full Text] [Related]
13. Frosted branch angiitis after allogeneic haematopoietic stem cell transplantation in adult T-cell leukaemia-lymphoma.
Kamoi K; Kato S; Uchimaru K; Tojo A; Ohno-Matsui K
Lancet Haematol; 2020 Oct; 7(10):e772. PubMed ID: 32976754
[No Abstract] [Full Text] [Related]
14. [Adult T-cell leukemia/lymphoma].
Yoshimitsu M
Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma with HTLV-1-associated myelopathy.
Sakamoto H; Itonaga H; Sawayama Y; Kojima A; Chiwata M; Fujioka M; Kitanosono H; Horai M; Miyazaki T; Shiraishi H; Imaizumi Y; Yoshida S; Hata T; Yamano Y; Miyazaki Y
Int J Hematol; 2021 May; 113(5):765-769. PubMed ID: 33423163
[TBL] [Abstract][Full Text] [Related]
16. [Treatment approach for relapse of adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation].
Kato K
Rinsho Ketsueki; 2021; 62(5):505-511. PubMed ID: 34248128
[TBL] [Abstract][Full Text] [Related]
17. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
18. The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation.
Kato K; Uike N; Wake A; Yoshimitsu M; Tobai T; Sawayama Y; Takatsuka Y; Fukuda T; Uchida N; Eto T; Nakashima Y; Kondo T; Taguchi J; Miyamoto T; Nakamae H; Ichinohe T; Kato K; Suzuki R; Utsunomiya A;
Hematol Oncol; 2019 Feb; 37(1):54-61. PubMed ID: 30171618
[TBL] [Abstract][Full Text] [Related]
19. A case series of adult T-cell leukemia-lymphoma, associated with human T-cell leukemia virus type-1, at a single center in a non-viral-endemic metropolitan area.
Akuzawa Y; Tsukasaki K; Saeki T; Okamura D; Ishikawa M; Maeda T; Kohri M; Takahashi N; Matsuda A; Kawai N; Asou N
J Clin Exp Hematop; 2019; 59(3):108-111. PubMed ID: 31564712
[TBL] [Abstract][Full Text] [Related]
20. The current status of therapy for adult T-cell leukaemia-lymphoma in Japan.
Yamada Y; Tomonaga M
Leuk Lymphoma; 2003 Apr; 44(4):611-8. PubMed ID: 12769337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
